Press release
RNA Based Therapeutic Market Update 2023: Projected to Cross Market Value of USD 25.12 Billion by 2030
Key Takeaways:
Growing Market: The RNA-based therapeutics market has experienced significant growth in recent years and is expected to continue expanding. Advances in RNA technology, particularly in the field of RNA interference (RNAi) and messenger RNA (mRNA), have fueled this growth.
RNA Interference (RNAi): RNAi is a process by which small interfering RNA (siRNA) molecules can target and silence specific genes, inhibiting the production of disease-causing proteins. RNAi-based therapeutics have shown promise in treating various diseases, including cancer, genetic disorders, and viral infections.
Messenger RNA (mRNA): mRNA-based therapeutics work by delivering synthetic mRNA molecules into cells, instructing them to produce therapeutic proteins. mRNA vaccines, such as the mRNA COVID-19 vaccines developed by Pfizer-BioNTech and Moderna, have demonstrated the potential of this technology.
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/546
Market Segmentation:
Product Type:
RNA Interference (RNAi) Therapeutics: This segment includes RNAi-based drugs that use small interfering RNA (siRNA) molecules to target and silence specific disease-causing genes.
Messenger RNA (mRNA) Therapeutics: This segment includes mRNA-based drugs that deliver synthetic mRNA molecules to instruct cells to produce therapeutic proteins.
Therapeutic Application:
Oncology: RNA-based therapeutics have shown promise in the treatment of various types of cancer by targeting specific oncogenes or inhibiting tumor growth pathways.
Infectious Diseases: RNA-based therapeutics can be used to combat viral infections by targeting viral genes or interfering with the replication process.
Genetic Disorders: RNA-based therapeutics hold potential for treating genetic disorders by targeting and correcting disease-causing genetic mutations.
Cardiovascular Disorders: RNA-based therapeutics may be employed to modulate gene expression and address cardiovascular diseases, such as high cholesterol or heart failure.
Neurological Disorders: RNA-based therapies can target specific genes involved in neurological disorders, including neurodegenerative diseases like Alzheimer's and Parkinson's.
Route of Administration:
Systemic Delivery: Therapeutics administered systemically, such as intravenous (IV) infusion, allow the RNA-based drugs to circulate throughout the body.
Local Delivery: Some RNA-based therapeutics may be delivered directly to a specific target site or organ, such as intratumoral injections for cancer treatment.
Geography:
The market can also be segmented based on geographic regions, such as North America, Europe, Asia-Pacific, and Rest of the World, as each region may have variations in regulatory frameworks, healthcare infrastructure, and market dynamics.
Request for Customization -
https://www.alliedmarketresearch.com/request-for-customization/546
Competitive Landscape:
Alnylam Pharmaceuticals
Moderna Therapeutics
BioNTech SE
Arrowhead Pharmaceuticals
Ionis Pharmaceuticals
Translate Bio
Regulus Therapeutics
Dicerna Pharmaceuticals
Arbutus Biopharma
Quark Pharmaceuticals
Buy this Premium Research Report:
https://www.alliedmarketresearch.com/purchase-enquiry/546
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Browse more latest healthcare reports:
Microfluidic Devices Market https://www.alliedmarketresearch.com/microfluidic-devices-market-A17085
Nucleic Acid Therapeutics Market https://www.alliedmarketresearch.com/nucleic-acid-therapeutics-market-A17089
Angiography Devices Market https://www.alliedmarketresearch.com/Angiography-devices-market
Exosome Diagnostic and Therapeutic Market https://www.alliedmarketresearch.com/exosome-diagnostic-and-therapeutic-market
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Based Therapeutic Market Update 2023: Projected to Cross Market Value of USD 25.12 Billion by 2030 here
News-ID: 3077667 • Views: …
More Releases from Allied Market Research
Horse Betting Market's CAGR Surge: A USD Billion Dollar Growth Story 2022 - 2032
Horse betting, one of the oldest forms of bet, has evolved dramatically over the centuries. From its origins in ancient civilizations to the high-tech, data-driven industry it is today, the horse betting market has adapted to cultural, technological, and economic shifts. This article explores the current landscape of the horse betting market, its challenges, opportunities, and the factors driving its growth.
The horse betting market was valued at $44.3 billion in…
Password Management Market Growing at a 20.7% CAGR Reach USD 15.2 Billion by 203 …
Allied Market Research published a new report, titled, " Password Management Market Growing at a 20.7% CAGR Reach USD 15.2 Billion by 2032 ." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and…
Cloud Artificial Intelligence Market Growing at 35.8% CAGR Reach USD 887 Billion …
Allied Market Research published a new report, titled, "Cloud Artificial Intelligence Market Growing at 35.8% CAGR Reach USD 887 Billion by 2032." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determine…
Microserver Market Growing at 15.8% CAGR Reach USD 122.4 Billion by 2032
Allied Market Research published a new report, titled, "Microserver Market Growing at 15.8% CAGR Reach USD 122.4 Billion by 2032." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determine steps to…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
